PL2582390T3 - Sposób immunoterapeutyczny obejmujący przeciwciała przeciwko CD123 (IL-3R) oraz kompleks immunostymulacyjny - Google Patents
Sposób immunoterapeutyczny obejmujący przeciwciała przeciwko CD123 (IL-3R) oraz kompleks immunostymulacyjnyInfo
- Publication number
- PL2582390T3 PL2582390T3 PL11794953T PL11794953T PL2582390T3 PL 2582390 T3 PL2582390 T3 PL 2582390T3 PL 11794953 T PL11794953 T PL 11794953T PL 11794953 T PL11794953 T PL 11794953T PL 2582390 T3 PL2582390 T3 PL 2582390T3
- Authority
- PL
- Poland
- Prior art keywords
- antibodies
- method involving
- immunostimulating complex
- immunotherapeutic method
- immunotherapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35498610P | 2010-06-15 | 2010-06-15 | |
| PCT/AU2011/000725 WO2011156860A1 (en) | 2010-06-15 | 2011-06-15 | IMMUNOTHERAPEUTIC METHOD INVOLVING CD123 (IL-3Rα) ANTIBODIES AND IMMUNOSTIMULATING COMPLEX |
| EP11794953.7A EP2582390B1 (en) | 2010-06-15 | 2011-06-15 | Immunotherapeutic method involving cd123 (il-3r ) antibodies and immunostimulating complex |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2582390T3 true PL2582390T3 (pl) | 2015-05-29 |
Family
ID=45347584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11794953T PL2582390T3 (pl) | 2010-06-15 | 2011-06-15 | Sposób immunoterapeutyczny obejmujący przeciwciała przeciwko CD123 (IL-3R) oraz kompleks immunostymulacyjny |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8920803B2 (pl) |
| EP (1) | EP2582390B1 (pl) |
| AU (1) | AU2011267837B2 (pl) |
| DK (1) | DK2582390T3 (pl) |
| ES (1) | ES2530977T3 (pl) |
| PL (1) | PL2582390T3 (pl) |
| WO (1) | WO2011156860A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2814962T3 (es) | 2013-02-20 | 2021-03-29 | Novartis Ag | Fijación eficaz como objetivo de la leucemia humana primaria utilizando células T modificadas con receptor de antígeno quimérico anti-CD123 |
| US10174095B2 (en) | 2014-07-21 | 2019-01-08 | Novartis Ag | Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor |
| RU2020117196A (ru) | 2014-08-19 | 2020-10-15 | Новартис Аг | Химерный антигенный рецептор (car) против cd123 для использования в лечении злокачественных опухолей |
| ES2688035T3 (es) | 2014-08-29 | 2018-10-30 | Gemoab Monoclonals Gmbh | Receptor de antígeno universal que expresa células inmunes para direccionamiento de antígenos múltiples diversos, procedimiento para fabricación del mismo y utilización del mismo para tratamiento de cáncer, infecciones y enfermedades autoinmunes |
| MY191964A (en) * | 2015-01-23 | 2022-07-21 | Sanofi Sa | Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123 |
| EP3280442A4 (en) * | 2015-04-08 | 2018-10-31 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind cd123 |
| TW201709932A (zh) * | 2015-06-12 | 2017-03-16 | 西雅圖遺傳學公司 | Cd123抗體及其共軛物 |
| JP7438988B2 (ja) | 2018-06-13 | 2024-02-27 | ノバルティス アーゲー | Bcmaキメラ抗原受容体及びその使用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6177678B1 (en) | 1995-04-05 | 2001-01-23 | Brasscorp Ltd. | Method and apparatus for leak detection and non-destructive testing |
| WO1997024373A1 (en) | 1995-12-29 | 1997-07-10 | Medvet Science Pty. Limited | Monoclonal antibody antagonists to haemopoietic growth factors |
| WO2001066139A1 (en) * | 2000-03-06 | 2001-09-13 | University Of Kentucky Research Foundation | Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell |
| CA2471092A1 (en) | 2001-12-21 | 2003-07-10 | Antigenics Inc. | Compositions comprising immunoreactive reagents and saponins, and methods of use thereof |
| CN101896200A (zh) | 2007-12-06 | 2010-11-24 | Csl有限公司 | 抑制白血病干细胞的方法 |
-
2011
- 2011-06-15 PL PL11794953T patent/PL2582390T3/pl unknown
- 2011-06-15 WO PCT/AU2011/000725 patent/WO2011156860A1/en not_active Ceased
- 2011-06-15 US US13/704,583 patent/US8920803B2/en active Active
- 2011-06-15 EP EP11794953.7A patent/EP2582390B1/en active Active
- 2011-06-15 AU AU2011267837A patent/AU2011267837B2/en active Active
- 2011-06-15 ES ES11794953T patent/ES2530977T3/es active Active
- 2011-06-15 DK DK11794953.7T patent/DK2582390T3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011267837B2 (en) | 2016-06-23 |
| EP2582390A4 (en) | 2013-11-06 |
| WO2011156860A1 (en) | 2011-12-22 |
| DK2582390T3 (en) | 2015-02-23 |
| US8920803B2 (en) | 2014-12-30 |
| US20130149303A1 (en) | 2013-06-13 |
| EP2582390A1 (en) | 2013-04-24 |
| EP2582390B1 (en) | 2014-11-19 |
| ES2530977T3 (es) | 2015-03-09 |
| AU2011267837A1 (en) | 2013-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250624A0 (en) | Anti-fgfr3 antibodies and methods of using them | |
| IL250691A0 (en) | Anti-ox40 antibodies and methods of using them | |
| ZA201207484B (en) | Humanized anti-egfl7 antibodies and methods using same | |
| IL244197A0 (en) | Antibodies against cd100 and methods of using them | |
| EP2624066A4 (en) | LOADING ELEMENT AND METHOD FOR THE MANUFACTURE THEREOF | |
| IL240898A0 (en) | Antibodies against a5c and methods of using the antibodies | |
| PL2606064T3 (pl) | Sposoby wytwarzania wieloswoistych i wielowartościowych przeciwciał | |
| HUE037095T2 (hu) | Eljárások és reagensek monoklonális ellenanyagok elõállítására | |
| PL2552783T3 (pl) | Saszetkarka o dużej szybkości i odpowiedni sposób | |
| PL2582390T3 (pl) | Sposób immunoterapeutyczny obejmujący przeciwciała przeciwko CD123 (IL-3R) oraz kompleks immunostymulacyjny | |
| EP2558587A4 (en) | METHOD FOR DISPLAYING ANTIBODIES | |
| PL2646466T3 (pl) | Środki i sposoby do wytwarzania przeciwciał o wysokim powinowactwie | |
| EP2589815A4 (en) | DRIVE AND METHOD FOR THE PRODUCTION THEREOF | |
| PL2621623T3 (pl) | Urządzenie i sposób wytwarzania wypełnionych perełek | |
| IL219136A0 (en) | Anti-hepsin antibodies and methods using same | |
| GB201010998D0 (en) | Sealing method and apparatus | |
| HK1186094A (en) | IMMUNOTHERAPEUTIC METHOD INVOLVING CD123 (IL-3Rα) ANTIBODIES AND IMMUNOSTIMULATING COMPLEX | |
| IL218438A0 (en) | Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof | |
| GB201008325D0 (en) | Apparatus and method for searching | |
| GB201008288D0 (en) | Search apparatus and method | |
| HK1165434A (en) | Humanized anti-egfl7 antibodies and methods using same |